Atherosclerosis has been regarded as a form of chronic vascular inflammation. Numerous
biomarkers associated with inflammation have been identified as novel targets to monitor …

Inflammation is a key mechanism in atherosclerotic progression and destabilization that
precedes clinical events such as myocardial infarction. The inflammatory biomarkers provide …

Current evidence supports that inflammation is a major driving force underlying the initiation
of coronary plaques, their unstable progression, and eventual disruption; patients with a …

Inflammation is widely considered to be an important contributing factor of the
pathophysiology of coronary heart disease (CHD), and the inflammatory cascade is …

Inflammation plays a pivotal role in all stages of atherosclerosis from endothelial dysfunction
and plaque formation to plaque destabilization and disruption. Inflammatory biomarkers …

Introduction Inflammation has been implicated in the development of atherosclerosis in
patients with acute coronary syndrome. C-reactive protein is an established nonspecific …

It is now generally recognized that atherosclerosis is a chronic inflammatory disease,
characterized by overrecruitment of leukocytes (monocytes and T-cells) to the site of …

Recent investigations of atherosclerosis have focused on inflammation, providing new
insight into mechanisms of disease. Inflammatory cytokines involved in vascular …

Inflammation plays a key role in the pathogenesis of atherosclerosis. Understanding the
process of inflammation as it pertains to atherosclerosis has provided researchers with …

Atherosclerotic cardiovascular disease (CVD) remains the leading cause of mortality
worldwide. While conventional risk factors have been studied and managed, CVD continues …